National Strategy for Control and Prevention of Non-communicable Diseases in Kingdom of Bahrain 2014 – 2025

1.1. Raising awareness about the risk factors for non- communicable diseases.

1.2. Promoting healthy nutrition and physical activity among different groups in society.

1.3. Establishing legislation and policies to reduce risk factors in the community. 11 Second strategic goal Secondary Prevention of Non-communicable Diseases Goals Indicators Early detection of risk factors and The proportion of individuals who non-communicable diseases have been screened to detect risk factors from the target groups. Implementation strategies

2.1. Early detection of diseases and risk factors among high risk groups. 12 The third strategic goal: Improving the quality of health services at the three levels provided for patients with non-communicable diseases and their complications Goals Indicators An 80% availability of the • Availability and affordability of quality, affordable basic technologies safe and efficacious essential non and essential medicines, communicable disease medicines, including generics, required to including generics, and basic treat major non communicable technologies* in both public and diseases in both public and private facilities. private facilities. At least 50% of eligible people • Proportion of eligible persons receive drug therapy and (defined as aged 40 years and older counseling (including glycemic with a 10-year cardiovascular risk control) to prevent heart attacks ≥30%, including those with existing and strokes. cardiovascular disease) receiving drug therapy and counseling (including glycemic control) to prevent heart attacks and strokes. Creating and updating the • The existence of national updated clinical guidelines for health evidence- based clinical guidelines workers working with non- for non-communicable diseases. communicable diseases on a • The proportion of doctors following regular basis and the level of the guidelines in the field of treatment application of the guidelines, of non-communicable diseases. according to the indicators. Developing a clear referral system • The existence of an enabled referral policy from primary care to system between primary and specialized secondary & tertiary specialized secondary & tertiary care. care. 13 Implementation strategies

3.1. Improve the infrastructure of primary health-care centers to make them more suitable for the management of non- communicable diseases. 3.2. provision of qualified human resources in the field of in non- communicable diseases.

3.3. Upgrading the qualification of health workers in primary health care to be able to deal with non-communicable diseases.

3.4. Improving of secondary and tertiary care services provided for non-communicable diseases. * Essential medicines include at least: aspirin, a statin, an angiotensin converting enzyme inhibitor, thiazide diuretic, a long acting calcium channel blocker, metformin, insulin, a bronchodilator and a steroid inhalant. * Basic technologies include at least: blood pressure measurement device, a weighing scale, height measuring equipment, blood sugar and blood cholesterol measurement devices with strips and urine strips for albumin assay. 14 The fourth strategic goal: Conducting and supporting research and studies for non-communicable diseases and its complications Goals Indicators Promote studies and • Number of studies and research of national research of national health systems for non-communicable health systems for non- diseases. communicable diseases Implementation strategies

4.1. Study the burden of disease and risk factors for non- communicable diseases periodically. The fifth strategic goal: Empower patients and their families to contribute To control of non-communicable diseases and its complications Goals Indicators Engaging patients and their • The proportion of patients proficient in families to take responsibility control of non-communicable diseases for their health management among patients attending health services. Implementation strategies

5.1. Involvement of people with non-communicable diseases and their families to bear the responsibilities for treatment and prevention of complications.

5.2. To provide the necessary care and support to people with non-communicable diseases and their families.

5.3. Provides diagnostic, curative and rehabilitative needs necessary for patients with non-communicable diseases. 15 The sixth strategic goal: Non-communicable Community Partnership for Disease Control Goals Indicators Activating the partnership with • The establishment of a national government institutions and non- council / committee and a governmental organizations, private national multi-sectorial health sector and civil society to bear promotion and control for non- national responsibility to confront the communicable diseases. non-communicable diseases Implementation strategies

6.1. Involve government agencies, civil societies and the private sector in prevention and control of non-communicable diseases. The seventh strategic goal: Strengthening the means of surveillance, monitoring and evaluation For non-communicable diseases Goals Indicators The existence of an advanced national • The existence of a well-established registry based on quality standards national NCD surveillance system. (epidemiological surveillance system) for monitoring, follow-up and evaluation of non-communicable diseases Application of quality indicators • The proportion of health centers applying the standardized national clinical guidelines for the treatment of non-communicable diseases. Implementation strategies

7.1. Develop a comprehensive database to enable evaluation and monitoring of NCD programs.

7.2. Carry out annual evaluation of performance indicators for non-communicable diseases. 16